Transgenomic (TBIO) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
INCOME TAX EXPENSE (BENEFIT): 0
Today's EPS Names:
OMID, SICP, SCKT, More
Financial Fact:
INCOME TAX EXPENSE (BENEFIT): 0
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q4 EPS of ($0.28), $0.13 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $7.2 million.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Norwood Financial Corp (NWFL) Tops Q3 EPS by 13c
- Corning shares rise 3% in premarket trade after Q3 EPS, revenue beat estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
